CareMetx Names Kurt Brumme as New CEO

Bethesda, MD, Nov. 03, 2026 /CourierPR/ -- CareMetx, a leading provider of technology-enabled patient access and pharmacy solutions to pharmaceutical manufacturers, has appointed Kurt Brumme as its new Chief Executive Officer (CEO). Brumme, who previously served as the company’s Chief Financial Officer (CFO) since 2025, will now lead the organization in its next phase of growth.

Brumme joined CareMetx in 2025, bringing with him a wealth of experience in the healthcare sector. With more than 20 years in roles spanning healthcare and investing, he has a proven track record of building and scaling high-growth companies. His background includes experience in healthcare technology, outsourced payer services, and biopharma commercialization.

The appointment comes at a pivotal moment for CareMetx. The company has made significant strides, advancing its core technology platform and expanding its scale through the acquisition of Cencora’s U.S. patient services and free goods pharmacy business. These strategic investments position CareMetx to impact more patients and providers, while continuing to expand its client footprint and reach across the broader commercialization ecosystem.

Morris will continue to lead CareMetx’s strategy and commercial efforts in his current role. He will help align innovative solutions with client needs and maintain the company’s commercial momentum.

Founded in 2011, CareMetx has a decade of experience supporting patients and manufacturers across the most complex access environments. The company has built a strong foundation in compassionate advocacy and operational execution, supporting more than 300 pharmaceutical brands as specialty therapies have expanded in scale and complexity.

Under Brumme’s leadership, CareMetx aims to continue its mission of transforming complexity into clarity across the treatment journey, ensuring patients can access and afford life-saving treatments with fewer obstacles.